Real-time enrollment status for this heart and kidney disease clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 12:10 PM UTC
| NCT Number | NCT06531824 |
| Recruiting Status | Recruiting |
| Condition | Heart and Kidney Disease |
| Phase | PHASE3 |
| Target Enrollment | 11,000 participants |
| Active Locations | 42 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | June 24, 2026 (3 weeks ago) |
As of July 17, 2026: Clinical trial NCT06531824 is currently recruiting participants. This phase3 study for heart and kidney disease is actively seeking new participants at 42 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06531824 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 42 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06531824 was last updated 3 weeks ago (June 24, 2026). HelloStudys verifies this status automatically.